Retension Pharmaceuticals
RTSN
#9806
Rank
$96.6 M
Marketcap
$11.60
Share price
-1.65%
Change (1 day)
N/A
Change (1 year)

Retension Pharmaceuticals (RTSN) - Total assets

Total assets on the balance sheet as of June 2026 : $16.12 Million USD

According to Retension Pharmaceuticals's latest financial reports the company's total assets are $16.12 Million USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Retension Pharmaceuticals - Total assets on balance sheet (from 2025 to 2026)